Navigation Links
CataRhex PRO

ProductsCataRhex PRO
Company Toshbro Pvt. Ltd.
Item CataRhex PRO
Features Compact, light weight and truly portable (weight 5.8 Kg), mounts directly on any standard I/V pole, simple tubing system, short re-set time between surgeries, ready for laser phaco, inbuilt RF capsulotomy.
Description CataRhex PRO the portable cataract extraction system with automated capsulotomy.
Info Toshbro Pvt. Ltd.
Customer Service: (022) 24900672
Web site: http://www.toshbromedicals.com/

Related medicine products :

1. Silicone Oil Cannula System - 20 Gauge
2. Silicone Oil Cannula System - 19 Gauge
3. SuperVu Galilean System
4. KOWA nonmyd 7 / VK-2 Digital Imaging System
5. KOWA nonmyd a-D / VK-2 Digital Imaging System
6. Refraction System RT-2100
7. Odyssey Phacoemulsification System
8. SIStem Phacoemulsification System
9. Precisionist Phacoemulsification System
10. Photon Laser Phacoemulsification System
11. Compact Ultrasonic Phacoemulsification System
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products:
(Date:12/4/2008)...ratic, study finds , , THURSDAY, Dec. 4...gned to protect against cervical cancer are rare, ..., That,s the assessment of Australian researchers ... the Gardasil vaccine were given to girls in secon...il protects against four types of human papillomav...
(Date:12/4/2008)...ewswire-FirstCall/ - Haemacure Corporation (TSX:HA...mpany developing high-value, human plasma-derived ...that is has confirmed the successful operation qua...ent at its new state-of-the-art plasma fractionati...excited that we have achieved the important milest...
(Date:12/4/2008)...- Although there are many issues,facing Americans..., the War in,Iraq -- the Holiday Season is always... and friends. But this holiday season may be even ...ced the death of a loved one.,Their loss combined...h greater,sadness, emptiness and loss. , "...
(Date:12/4/2008)...rado Trails the Nation in Giving as Demand for Non...RNewswire/ -- More than half of Coloradans report ...o charitable causes during the economic downturn, ...," the first statewide philanthropy study in Color...tober 2008. With demand for services increasing, t...
Breaking Medicine News(10 mins):Health News:Cervical Cancer Vaccine Well Tolerated 2Health News:Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL 2Health News:Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL 3Health News:In-House Hospice Offers Help to Those Living With Grief During Holiday Time 2Health News:Economy Doesn't Dampen Colorado's Giving Spirit According to Statewide Giving and Volunteering Study 2Health News:Economy Doesn't Dampen Colorado's Giving Spirit According to Statewide Giving and Volunteering Study 3Health News:Economy Doesn't Dampen Colorado's Giving Spirit According to Statewide Giving and Volunteering Study 4
...alth agencies with the most effective ways of stop...onal communication and proper condom use, for exam...om consideration needle-exchange and substance-abu...ble for federal funding despite evidence of their ...
...Family Restaurant at Lloydminister, has tested pos... a virus and affects the liver and causes fever, f...comfort followed by yellow jaundice a few days lat...n of this virus from the worker to patrons of the ...
...as published the findings of the first human test ...dysfunction.// The finding shows that gene therapy...rugs, since gene therapy is beneficial for months,... treatment for erectile dysfunction. Lead author...
... heart diseases were earlier considered illnesses ...number of young people affected// with these ailme...ished in the December edition of the Mayo Clinic P... of metabolic syndrome is increasing these days. ...
Other Medicine News:Health News:Best HIV-Prevention Programs Help People Build Skills 2Health News:Best HIV-Prevention Programs Help People Build Skills 3Health News:Gene Therapy May Be the Solution for Erectile Dysfunction 2Health News:Young and Obese People Heading for Heart Trouble 2
(Date:12/3/2008)...if., Dec. 3 Isis Pharmac...that OncoGenex Pharmaceuticals, Inc.,provided pos...linical trial of,OGX-011 in combination with doce... to docetaxel and prednisone alone ("the control a...ate resistant prostate cancer. The current 10.6,...
(Date:12/3/2008)...c. 3 Vical Incorporated,...inding letter of intent with EIP,Eczacibasi Ilac ...e company,s,Allovectin-7(R) immunotherapeutic pro... of Northern Cyprus. EIP has agreed to obtain the ...and to pay Vical upfront and milestone payments,p...
(Date:12/2/2008)... 3 Breast-specific gamm... cancers not found on mammograms or by,clinical e...nnual meeting of,the Radiological Society of Nort...most difficult to detect breast cancer-invasive,l..., M.D., professor of,radiology and director of th...
(Date:12/2/2008)... Dec. 2 IBT Laboratories, a leadin...boratory specializing in immunology and allergy as... evaluate the response of patients whose immune s...eficiency disorder, chemotherapy drugs, or because...nt rejection of a transplant. The company launched...
Breaking Medicine Technology:Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Schedules Revised for Flu Meningitis Vaccines 9466 1Schedules Revised for Flu Meningitis Vaccines 9466 2Time Critical Diagnosis Task Force Convenes in Jefferson City 9465 1Time Critical Diagnosis Task Force Convenes in Jefferson City 9465 2Manufacturing Organizations Identify Efficiencies in Maintenance Functions 9463 1Manufacturing Organizations Identify Efficiencies in Maintenance Functions 9463 2PCMA 3A New Study on Independent Pharmacy Reimbursements Will Raise Eyebrows on Capitol Hill 9461 1PCMA 3A New Study on Independent Pharmacy Reimbursements Will Raise Eyebrows on Capitol Hill 9461 2
... SAN FRANCISCO--(BUSINESS WIRE)--May 21, 2007 - Gi...results of two long-term studies,evaluating ambris...gonist (ERA) for the treatment of patients with pu...rm data are from patients,who originally participa... AMB-222, a Phase II study of patients who had,pre...
... Relationship Between Ability to Function and Trea...died, INDIANAPOLIS, May 21, 2007 /PRNewswire-First...ed anxiety disorder (GAD),treated with Cymbalta(R)...perform everyday activities at home, work and in s...rovements in global,functioning were the result of...
Other Medicine Technology:Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 2Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 3Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 4Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 6Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 2Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 3Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 4Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 5Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 6